Dexamethasone/Tobramycin

地塞米松/妥布霉素

Report date: 2026/03/09 20:02:04

Base Information

Drug NameDexamethasone/Tobramycin
Drug Alias Name妥布霉素/地塞米松Tobramycin/Dexamethasone妥布霉素地塞米松tobramycin and dexamethasonedexamethasone and tobramycin +[10] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists30S ribosomal subunit inhibitors
TargetsGlucocorticoid receptor30S ribosomal subunit
Therapy Area/IndicationsInflammationCataractXerophthalmia +[6] 
Global Approved IndicationsEye Infections
Approved Indications in ChinaEye Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1988/08/18
Country/TerritoryUnited StatesBrazilMainland China
CombinationsYes DexamethasoneTobramycin
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAlcon Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesSandozQilu Pharmaceutical Co Ltd
Inactive CompaniesAzidus BrasilAlconSutphin Drugs Inc +[4] 
Active IndicationsEye Infections
Inactive IndicationsInflammationCataractXerophthalmia +[5] 

Other Information

ATC CodeS01CA01S02CA06S03CA01
Related LinksN/A